Skip to main content

Find Clinical Trials

Home
Conditions
Early Breast Cancer

Clinical trial condition

Early Breast Cancer

Explore clinical trials studying Early Breast Cancer. Study availability and eligibility vary by location and protocol.

55 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Early Breast Cancer trial results

Not yet recruiting

SHR-A1811 Plus Pertuzumab as Neoadjuvant Therapy for Early or Locally Advanced HR-Positive HER2-Positive Breast Cancer: A Prospective, Open-Label, Phase II Study

NCT07307287

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response

NCT07129187

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

NCT07101159

Conditions: Adjuvant Therapy, Breast Diseases, Breast Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy

NCT06623903

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
Locations: Department of Oncology, Aarhus University Hosptial Aarhus N, Central Jutland, Denmark

View Trial Details

Not yet recruiting

Aromatherapy in the Treatment of Early Breast Cancer

NCT06435104

Conditions: Anxiety Disorders, Breast Diseases, Breast Neoplasms, +6 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer

NCT06404463

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer

NCT06404736

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +7 more
Locations: Zhimin Shao Shanghai, Not US/Canada, China

View Trial Details

Not yet recruiting

Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab

NCT06371807

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
Locations: Fundaçao Champalimaud, Avenida Brasilia, Lisbon, Portugal

Centro Hospitalar Universitário Lisboa Norte E.P.E Lisbon, Portugal

Instituto Português de Oncologia Francisco Gentil, E.P.E Porto, Portugal

View Trial Details

Active, not recruiting

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

NCT03701334

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
Locations: University of Alabama at Birmingham-Kirklin Clinic Birmingham, Alabama, United States

Cancer Treatment Centers of America Goodyear, Arizona, United States

St Bernards Medical Center Jonesboro, Arkansas, United States

Comprehensive Blood and Cancer Bakersfield, California, United States

View all 386 locations

View Trial Details

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

NCT04961996

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
Locations: Southern Cancer Center Daphne, Alabama, United States

CBCC Global Research Inc., at Comprehensive Blood and Cancer Center Bakersfield, California, United States

St Joseph Heritage Healthcare Fullerton, California, United States

Long Beach Memorial Medical Center Long Beach, California, United States

View all 622 locations

View Trial Details